<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696289</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00035534</org_study_id>
    <nct_id>NCT04696289</nct_id>
  </id_info>
  <brief_title>Predicting Pediatric Pulmonary Vein Stenosis Outcomes Using Data Acquired During a Cardiac Catheterization</brief_title>
  <official_title>Predicting Pediatric Intraluminal Pulmonary Vein Stenosis Outcomes Using a Comprehensive Standardized Catheterization Assessment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single center study which applies a standardized, comprehensive&#xD;
      catheterization assessment to patients with a known or suspected diagnosis of pulmonary vein&#xD;
      stenosis (PVS) who are undergoing a cardiac catheterization at Boston Children's Hospital. As&#xD;
      part of the assessment, each pulmonary vein will undergo angiography (pictures using moving&#xD;
      x-rays and contrast dye), intravascular ultrasound (IVUS; pictures of the vein wall using a&#xD;
      catheter inside the vein), pressure assessment and compliance testing. The status of each&#xD;
      pulmonary vein will then be assessed 12 months after the catheterization (i.e. no disease,&#xD;
      severe disease, etc.). Using statistics, the investigators will determine which patient and&#xD;
      vein characteristics (obtained at the of catheterization) can predict whether or not a&#xD;
      pulmonary vein will have disease. The investigators hypothesize that this comprehensive,&#xD;
      standardized, invasive assessment of pediatric intraluminal PVS can predict vein outcome.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2021</start_date>
  <completion_date type="Anticipated">February 2025</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary vein status</measure>
    <time_frame>12 months +/- 6 weeks or prior to study exit due to death or lung transplant</time_frame>
    <description>Severity of pulmonary vein stenosis (score 0 to 3); Score 0: Unobstructed vein (best outcome), Score 1: Proximal vein disease, Score 2: Distal vein disease, Score 3: Vein atresia (worst outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient status</measure>
    <time_frame>12 months</time_frame>
    <description>Transplant free survival</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pulmonary Vein Stenosis</condition>
  <arm_group>
    <arm_group_label>Standardized catheterization assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of pulmonary veins including angiography, intravascular ultrasound, pressure assessment and compliance testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standardized catheterization assessment</intervention_name>
    <description>There are four components to the pulmonary vein assessment.&#xD;
Angiography: pulmonary artery wedge injection and/or selective pulmonary vein injection.&#xD;
Intravascular ultrasound: manual pullback of IVUS catheter from lobar segment to left atrium.&#xD;
Pressure assessment: pulmonary vein pressure (mmHg) measured before and after (if applicable) intervention.&#xD;
Compliance testing: the compliance of the vein will be measured using a compliant conventional balloon.</description>
    <arm_group_label>Standardized catheterization assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients undergoing cardiac catheterization for the indication of known or&#xD;
             suspicion for intraluminal pulmonary vein stenosis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamically unstable patients as determined by the patient care team.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Callahan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital/Harvard Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ryan Callahan, MD</last_name>
    <phone>6173558228</phone>
    <email>Ryan.Callahan@cardio.chboston.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zachary Gauthier, BS</last_name>
    <phone>6179196090</phone>
    <email>Zachary.Gauthier@cardio.chboston.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan Callahan, MD</last_name>
      <phone>617-355-8228</phone>
      <email>Ryan.Callahan@cardio.chboston.org</email>
    </contact>
    <contact_backup>
      <last_name>Zachary Gauthier, BS</last_name>
      <phone>617-919-6090</phone>
      <email>Zachary.Gauthier@cardio.chboston.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sadr IM, Tan PE, Kieran MW, Jenkins KJ. Mechanism of pulmonary vein stenosis in infants with normally connected veins. Am J Cardiol. 2000 Sep 1;86(5):577-9, A10.</citation>
    <PMID>11009286</PMID>
  </reference>
  <reference>
    <citation>Kovach AE, Magcalas PM, Ireland C, McEnany K, Oliveira AM, Kieran MW, Baird CW, Jenkins K, Vargas SO. Paucicellular Fibrointimal Proliferation Characterizes Pediatric Pulmonary Vein Stenosis: Clinicopathologic Analysis of 213 Samples From 97 Patients. Am J Surg Pathol. 2017 Sep;41(9):1198-1204. doi: 10.1097/PAS.0000000000000892.</citation>
    <PMID>28622179</PMID>
  </reference>
  <reference>
    <citation>Callahan R, Kieran MW, Baird CW, Colan SD, Gauvreau K, Ireland CM, Marshall AC, Sena LM, Vargas SO, Jenkins KJ. Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis. J Pediatr. 2018 Jul;198:29-35.e5. doi: 10.1016/j.jpeds.2018.01.029. Epub 2018 Mar 23.</citation>
    <PMID>29576325</PMID>
  </reference>
  <reference>
    <citation>Callahan R, Jenkins KJ, Gauthier Z, Gauvreau K, Porras D. Preliminary findings on the use of intravascular ultrasound in the assessment of pediatric pulmonary vein stenosis. Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E362-E370. doi: 10.1002/ccd.29264. Epub 2020 Sep 16.</citation>
    <PMID>32936535</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>Ryan Callahan</investigator_full_name>
    <investigator_title>Assistant Professor of Pediatrics</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stenosis, Pulmonary Vein</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

